TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
GlaxoSmithKline AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
903,088
|
853,015
|
782,166 |
Financial expenses |
886
|
303
|
2,403 |
Earnings before taxes |
27,789
|
27,949
|
29,144 |
Total assets |
292,017
|
272,133
|
341,506 |
Current assets |
210,343
|
195,315
|
261,761 |
Current liabilities |
175,730
|
155,846
|
225,707 |
Equity capital |
116,287
![]() |
116,287
|
115,799 |
- share capital |
950
![]() |
950
![]() |
950 |
Employees (average) | 56 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.8%
|
42.7%
|
33.9% |
Turnover per employee | 13,967 | ||
Profit as a percentage of turnover |
3.1%
|
3.3%
|
3.7% |
Return on assets (ROA) |
9.8%
|
10.4%
|
9.2% |
Current ratio |
119.7%
|
125.3%
|
116.0% |
Return on equity (ROE) |
23.9%
|
24.0%
|
25.2% |
Change turnover |
50,073
|
70,849
|
-93,428 |
Change turnover % |
6%
|
9%
|
-11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.